Related references
Note: Only part of the references are listed.Crosstalk Between β-CATENIN-Mediated Cell Adhesion and the WNT Signaling Pathway
Ding-Xi Liu et al.
DNA AND CELL BIOLOGY (2023)
Salinomycin as a potent anticancer stem cell agent: State of the art and future directions
Dan Qi et al.
MEDICINAL RESEARCH REVIEWS (2022)
The Wnt Pathway: From Signaling Mechanisms to Synthetic Modulators
Ellen Youngsoo Rim et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2022)
Biophysical Survey of Small-Molecule?-Catenin Inhibitors: ACautionary Tale
Michael A. McCoy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK
Benedicte Oules et al.
VIRCHOWS ARCHIV (2022)
Recent advances of fl-catenin small molecule inhibitors for cancer therapy: Current development and future perspectives
Panpan Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Premise and peril of Wnt signaling activation through GSK-3β inhibition
Samuel M. Law et al.
ISCIENCE (2022)
The Casein kinase 1α agonist pyrvinium attenuates Wnt-mediated CK1α degradation via interaction with the E3 ubiquitin ligase component Cereblon
Chen Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug
Junyi Ren et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Pyrvinium doubles against WNT-driven cancer
Jiaming Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Wnt/beta-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
Alexander Chehrazi-Raffle et al.
CANCERS (2021)
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours
Jordi Rodon et al.
BRITISH JOURNAL OF CANCER (2021)
CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer
Simon Uzor et al.
SCIENTIFIC REPORTS (2021)
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy
Nicholas C. DeVito et al.
CELL REPORTS (2021)
Are We Benign? What Can Wnt Signaling Pathway and Epithelial to Mesenchymal Transition Tell Us about Intracranial Meningioma Progression
Anja Bukovac et al.
CANCERS (2021)
Cell Biology of Canonical Wnt Signaling
Lauren V. Albrecht et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 37 (2021)
WNT as a Driver and Dependency in Cancer
Marie J. Parsons et al.
CANCER DISCOVERY (2021)
Methylation Patterns of DKK1, DKK3 and GSK3 beta Are Accompanied with Different Expression Levels in Human Astrocytoma
Anja Kafka et al.
CANCERS (2021)
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Jeroen M. Bugter et al.
NATURE REVIEWS CANCER (2021)
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer
S. Lindsey Davis et al.
INVESTIGATIONAL NEW DRUGS (2020)
The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
Betty Y. Tam et al.
CANCER LETTERS (2020)
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons
Nupur Mukherjee et al.
CLINICAL BREAST CANCER (2020)
Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells
Jinhua Zhang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2020)
Targeting the beta-catenin signaling for cancer therapy
Xue Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
Nuclear Regulation of Wnt/β-Catenin Signaling: It's a Complex Situation
Christin C. Anthony et al.
GENES (2020)
WNT Signaling in Melanoma
Anna Gajos-Michniewicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
Kirsten Stromme Kierulf-Vieira et al.
CANCERS (2020)
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Jennifer R. Diamond et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles
Mohammad Norouzi et al.
SCIENTIFIC REPORTS (2020)
Targeting the Wnt/β-catenin signaling pathway in cancer
Ya Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Walking the tight wire between cell adhesion and WNT signalling: a balancing act for β-catenin
Tanne van der Wal et al.
OPEN BIOLOGY (2020)
SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong antitumor effects and Wnt pathway inhibition in castration-resistant prostate cancer (CRPC) models
Carine Bossard et al.
CANCER RESEARCH (2020)
SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong antitumor effects and Wnt and cyclin D-CDK4/6-RB pathway inhibition in hormone-receptor-positive (HR plus ) breast cancer models
Heekyung Chung et al.
CANCER RESEARCH (2020)
Salinomycin nanocrystals for colorectal cancer treatment through inhibition of Wnt/β-catenin signaling
Zhongyuan Wang et al.
NANOSCALE (2020)
Wnt/β-catenin signaling cascade: A promising target for glioma therapy
Lu He et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Xiaofei Cheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors
Fumiyuki Shirai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
Harmen van Andel et al.
LEUKEMIA (2019)
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
Jerry Harb et al.
CURRENT ONCOLOGY REPORTS (2019)
High content screening identifies monensin as an EMT-selective cytotoxic compound
Marion Vanneste et al.
SCIENTIFIC REPORTS (2019)
The Wnt signaling pathway: a potential therapeutic target against cancer
Noyel Ghosh et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
Mechanisms of intercellular Wnt transport
Daniel Routledge et al.
DEVELOPMENT (2019)
Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors
Peng Sang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs
Anna Markowska et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer
Christopher H. Lieu et al.
CLINICAL CANCER RESEARCH (2019)
The Delivery of a Wnt Pathway Inhibitor Toward CSCs Requires Stable Liposome Encapsulation and Delayed Drug Release in Tumor Tissues
Chong Li et al.
MOLECULAR THERAPY (2019)
A phase 1b dose escalation study of ipafricept (OMP-54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Kathleen N. Moore et al.
GYNECOLOGIC ONCOLOGY (2019)
PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers
Zheng Zhong et al.
ONCOGENE (2019)
SFRPs Are Biphasic Modulators of Wnt-Signaling-Elicited Cancer Stem Cell Properties beyond Extracellular Control
Chi-Jung Liang et al.
CELL REPORTS (2019)
Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling
Dattatrya Shetti et al.
CELLS (2019)
Medulloblastoma in the age of molecular subgroups: a review
Kyle Juraschka et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2019)
Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy
Jiangbo Wang et al.
BIOCHEMICAL JOURNAL (2019)
Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions
Phuong N. Le et al.
MOLECULAR CARCINOGENESIS (2019)
Inhibition of tumor growth and post-treatment regrowth by SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, in combination with standard of care in pancreatic cancer models
Carine Bossard et al.
CANCER RESEARCH (2019)
Hepatocellular Carcinoma: Etiology and Current and Future Drugs
Aastha Jindal et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Glioma epigenetics: From subclassification to novel treatment options
Olga Gusyatiner et al.
SEMINARS IN CANCER BIOLOGY (2018)
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients
Anne-Laure Giraudet et al.
BMC CANCER (2018)
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Nithya Krishnamurthy et al.
CANCER TREATMENT REVIEWS (2018)
Casein kinase 1α: biological mechanisms and theranostic potential
Shaojie Jiang et al.
CELL COMMUNICATION AND SIGNALING (2018)
Chemical biology of salinomycin
Antoine Versini et al.
TETRAHEDRON (2018)
The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor
Mariachiara Zuccarini et al.
GENES (2018)
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
Brandon Bumbaca et al.
ACTA PHARMACEUTICA SINICA B (2018)
RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model
Anna Mizutani et al.
CANCER SCIENCE (2018)
A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties
Zvezdan Pavlovic et al.
MABS (2018)
Contribution of the Wnt Pathway to Defining Biology of Glioblastoma
Marton Tompa et al.
NEUROMOLECULAR MEDICINE (2018)
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer (vol 13, e0198389, 2018)
Michael T. Schweizer et al.
PLOS ONE (2018)
Hypermethylation of Secreted Frizzled Related Protein 1 gene promoter in different astrocytoma grades
Anja Kafka et al.
CROATIAN MEDICAL JOURNAL (2018)
Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes
Pedro P. G. Guimaraes et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
Babita Madan et al.
BONE RESEARCH (2018)
Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
Ahmed M. Khalaf et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2018)
The tankyrase inhibitor G007-LK inhibits small intestine LGR5(+) stem cell proliferation without altering tissue morphology
Jens Henrik Norum et al.
BIOLOGICAL RESEARCH (2018)
Wnt signaling and cellular metabolism in osteoblasts
Courtney M. Karner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
AKT/GSK3β Signaling in Glioblastoma
Ewelina Majewska et al.
NEUROCHEMICAL RESEARCH (2017)
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors
Martina Ferri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Aberrant Wnt signaling: a special focus in CNS diseases
Mercedes Arnes et al.
JOURNAL OF NEUROGENETICS (2017)
A novel resveratrol-salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis
Rajkumar Venkatadri et al.
PHARMACOLOGICAL REPORTS (2017)
Modulating the wnt signaling pathway with small molecules
Freddi Huan Tran et al.
PROTEIN SCIENCE (2017)
Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics
Roya Tabatabai et al.
TARGETED ONCOLOGY (2017)
Salinomycin: A new paradigm in cancer therapy
Jayant Dewangan et al.
TUMOR BIOLOGY (2017)
Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
Matthew McCord et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
Shuang Shang et al.
ONCOTARGET (2017)
Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma
Yi Zhu et al.
ONCOTARGET (2017)
Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
Chongyuan Zhang et al.
MEDICAL SCIENCE MONITOR (2017)
WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death
Marcus M. Fischer et al.
SCIENCE ADVANCES (2017)
Niclosamide: Beyond an antihelminthic drug
Wei Chen et al.
CELLULAR SIGNALLING (2017)
Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy
Yung Lyou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors
Dario Zimmerli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway
Lei Zheng et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling
Xiaoping Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Wnt/Planar Cell Polarity Signaling: New Opportunities for Cancer Treatment
Avais M. Daulat et al.
TRENDS IN CANCER (2017)
The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic?
Vitezslav Bryja et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
WNT signaling in glioblastoma and therapeutic opportunities
Yeri Lee et al.
LABORATORY INVESTIGATION (2016)
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
B. Madan et al.
ONCOGENE (2016)
Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)
W. Messersmith et al.
ANNALS OF ONCOLOGY (2016)
The Wnt signaling pathway in cancer
Yann Duchartre et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells
Liang Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Visualization of a short-range Wnt gradient in the intestinal stem-cell niche
Homier F. Farin et al.
NATURE (2016)
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C. Arend et al.
ONCOTARGET (2016)
Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling
So-Young Hwang et al.
CELL REPORTS (2016)
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
Kamal Ahmed et al.
CANCERS (2016)
Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with paclitaxel (P) in patients (pts) with 1st-to 3rd-line metastatic HER2-negative breast cancer (BC).
Monica M. Mita et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Final results of a phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX.
Andrew H. Ko et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Ongoing Phase 1a/1b Dose-Finding Study of CWP232291 (CWP291) in Relapsed or Refractory Multiple Myeloma (MM)
Sung-Soo Yoon et al.
BLOOD (2016)
Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
Laura Novellasdemunt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Phuong N. Le et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis
Leticia F. Leal et al.
ONCOTARGET (2015)
Targeting the Tcf4 G13ANDE17 Binding Site To Selectively Disrupt β-Catenin/T-Cell Factor Protein-Protein Interactions
Zheng Huang et al.
ACS CHEMICAL BIOLOGY (2014)
The cellular story of dishevelleds
Anja Kafka et al.
CROATIAN MEDICAL JOURNAL (2014)
Factors Affecting the Nuclear Localization of β-Catenin in Normal and Malignant Tissue
Rhys G. Morgan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence
I. Ramachandran et al.
CELL DEATH & DISEASE (2014)
Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation
Andrea Venerando et al.
BIOCHEMICAL JOURNAL (2013)
Frizzled receptors signal through G proteins
Andrea S. Nichols et al.
CELLULAR SIGNALLING (2013)
CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
Roseli da Silva et al.
CLINICS (2013)
Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Andrey Voronkov et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells
Kun-Song Zhang et al.
ONCOLOGY REPORTS (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Wnt Signaling in Vertebrate Axis Specification
Hiroki Hikasa et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Secreted and Transmembrane Wnt Inhibitors and Activators
Cristina-Maria Cruciat et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
The beta-Catenin Destruction Complex
Jennifer L. Stamos et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Frizzled7 as an emerging target for cancer therapy
Taj D. King et al.
CELLULAR SIGNALLING (2012)
Drugging Wnt signalling in cancer
Paul Polakis
EMBO JOURNAL (2012)
The many faces and functions of β-catenin
Tomas Valenta et al.
EMBO JOURNAL (2012)
Specific Armadillo Repeat Sequences Facilitate β-Catenin Nuclear Transport in Live Cells via Direct Binding to Nucleoporins Nup62, Nup153, and RanBP2/Nup358
Manisha Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling
Bruno D. Fonseca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Inhibition of Tcf-4 Induces Apoptosis and Enhances Chemosensitivity of Colon Cancer Cells
Jiang Xie et al.
PLOS ONE (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
Kohichi Takada et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Andreas Jurgeit et al.
PLOS PATHOGENS (2012)
Frizzled 4 Regulates Stemness and Invasiveness of Migrating Glioma Cells Established by Serial Intracranial Transplantation
Xun Jin et al.
CANCER RESEARCH (2011)
Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2
Masayuki Kamino et al.
CANCER SCIENCE (2011)
Symmetric division versus asymmetric division: a tale of two coactivators
Michael Kahn
FUTURE MEDICINAL CHEMISTRY (2011)
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
Desheng Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Adenomatous polyposis coli tumour suppressor is essential for Axin complex assembly and function and opposes Axin's interaction with Dishevelled
Carolina Mendoza-Topaz et al.
OPEN BIOLOGY (2011)
Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes
Sima Babayeva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres
Shailender S. Kanwar et al.
MOLECULAR CANCER (2010)
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Louis Vermeulen et al.
NATURE CELL BIOLOGY (2010)
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Curtis A. Thorne et al.
NATURE CHEMICAL BIOLOGY (2010)
Wnt/β-Catenin Signaling Promotes Renal Interstitial Fibrosis
Weichun He et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy
Yingqun Wang
MOLECULAR CANCER THERAPEUTICS (2009)
Correlation between β-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma
Madeleine Austinat et al.
MOLECULAR CANCER (2008)
Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum
Laurence Abrami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Biological mechanisms of bone and cartilage remodelling-genomic perspective
F. Borovecki et al.
INTERNATIONAL ORTHOPAEDICS (2007)
Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity
Dexing Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Riccardo Fodde et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
β-Catenin destruction complex:: insights and questions from a structural perspective
D. Kimelman et al.
ONCOGENE (2006)
Monounsaturated fatty acid modification of Wnt protein: Its role in Wnt secretion
Ritsuko Takada et al.
DEVELOPMENTAL CELL (2006)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Wnt signalling in stem cells and cancer
T Reya et al.
NATURE (2005)
Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1
F Kuhnert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Distinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes
CJ Gottardi et al.
JOURNAL OF CELL BIOLOGY (2004)
Translocation of beta-catenin into the nucleus independent of interactions with FG-rich nucleoporins
EK Suh et al.
EXPERIMENTAL CELL RESEARCH (2003)
Role of Wnt pathway in medulloblastoma oncogenesis
N Yokota et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
WNT signals are required for the initiation of hair follicle development
T Andl et al.
DEVELOPMENTAL CELL (2002)
Share Paper
